Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy

Percutaneous revascularisation has evolved dramatically in the past few decades. The approach to the management of ischaemic heart disease has changed due to the development of new devices and techniques as well as the availability of new drugs and treatment strategies. Its use in combination with a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tamara García Camarero, José M de la Torre Hernández
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/ee6142e66f9d4614b35c8e41a8d1ecd8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ee6142e66f9d4614b35c8e41a8d1ecd8
record_format	dspace
spelling	oai:doaj.org-article:ee6142e66f9d4614b35c8e41a8d1ecd82021-12-04T16:02:29ZAntithrombotic Treatment After Coronary Intervention: Agreement and Controversy10.15420/ecr.2019.25.21758-37641758-3756https://doaj.org/article/ee6142e66f9d4614b35c8e41a8d1ecd82020-02-01T00:00:00Zhttps://www.ecrjournal.com/articleindex/ecr.2019.25.2https://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764Percutaneous revascularisation has evolved dramatically in the past few decades. The approach to the management of ischaemic heart disease has changed due to the development of new devices and techniques as well as the availability of new drugs and treatment strategies. Its use in combination with antiplatelet therapies has been essential to protect against stent thrombosis. The length of time this combination therapy is used has been modified in recent years and has been the subject of extensive research. The effect of prolonging the time it is taken or shortening it has been evaluated in different clinical conditions. In practice, the decisions regarding antithrombotic therapy after percutaneous coronary intervention are informed by the patient’s profile and the characteristics of the procedures performed. In this article, we review the use of antiplatelet/anticoagulant therapy after percutaneous coronary intervention focusing on trials and guidelines addressing variable durations for combination regimens and the alternatives.Tamara García CamareroJosé M de la Torre HernándezRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 15, Iss , Pp - (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Tamara García Camarero José M de la Torre Hernández Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
description	Percutaneous revascularisation has evolved dramatically in the past few decades. The approach to the management of ischaemic heart disease has changed due to the development of new devices and techniques as well as the availability of new drugs and treatment strategies. Its use in combination with antiplatelet therapies has been essential to protect against stent thrombosis. The length of time this combination therapy is used has been modified in recent years and has been the subject of extensive research. The effect of prolonging the time it is taken or shortening it has been evaluated in different clinical conditions. In practice, the decisions regarding antithrombotic therapy after percutaneous coronary intervention are informed by the patient’s profile and the characteristics of the procedures performed. In this article, we review the use of antiplatelet/anticoagulant therapy after percutaneous coronary intervention focusing on trials and guidelines addressing variable durations for combination regimens and the alternatives.
format	article
author	Tamara García Camarero José M de la Torre Hernández
author_facet	Tamara García Camarero José M de la Torre Hernández
author_sort	Tamara García Camarero
title	Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
title_short	Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
title_full	Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
title_fullStr	Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
title_full_unstemmed	Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
title_sort	antithrombotic treatment after coronary intervention: agreement and controversy
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/ee6142e66f9d4614b35c8e41a8d1ecd8
work_keys_str_mv	AT tamaragarciacamarero antithrombotictreatmentaftercoronaryinterventionagreementandcontroversy AT josemdelatorrehernandez antithrombotictreatmentaftercoronaryinterventionagreementandcontroversy
_version_	1718372768470269952

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy

Ejemplares similares